NICE recommends first oral treatment for migraine prevention

New guidance from NICE will  give 170,000 people in England more treatment options for preventing migraine attacks. The final draft guidance recommends that patients with both chronic and episodic migraines should be offered treatment with atogepant, the first oral preventative treatment option available for patients who suffer from migraines. The medication, made by AbbVie, is... Read moreThe post NICE recommends first oral treatment for migraine prevention appeared first on Nursing in Practice.
Source: Nursing in Practice - Category: Nursing Authors: Tags: Men's health Women's health headache migraine pain Source Type: news